Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Drug-Drug Interactions of Grazoprevir/Elbasvir in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a
- Status
- WITHDRAWN
- Phase
- PHASE2
Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)
- Status
- COMPLETED
- Phase
- PHASE3
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Investigating Dupilumab's Effect in Asthma by Genotype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers
- Status
- COMPLETED
- Phase
- NA
A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)
- Status
- COMPLETED
- Phase
- PHASE3
Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Optimization of Golimumab Treatment in Ulcerative Colitis
- Status
- UNKNOWN
- Phase
- PHASE4
Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)
- Status
- COMPLETED
- Phase
- PHASE4
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.
- Status
- COMPLETED
- Phase
- PHASE1
Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)
- Status
- COMPLETED
- Phase
- PHASE2